Trial intelligence / Profile preview

Propofol versus isoflurane effects on mtDNA expression during posterior spinal fixation surgery

IRCT20190121042444N5Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Dec 2023
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of propofol and isoflurane in Lumbar spine injury (LSI) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: mtDNA expression level, Duration of operation and 4 more. Started Dec 2023; status: completed.

02

Drugs

propofolisoflurane
03

Conditions

Lumbar spine injury (LSI)

Beyond the preview

Go deeper on IRCT20190121042444N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190121042444N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call